{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T17:44:02Z","timestamp":1740159842605,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T00:00:00Z","timestamp":1570752000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T00:00:00Z","timestamp":1570752000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["Progres Q40"],"award-info":[{"award-number":["Progres Q40"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Drug Metab Pharmacokinet"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s13318-019-00579-3","type":"journal-article","created":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T09:04:00Z","timestamp":1570784640000},"page":"71-80","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of Neutrophil Gelatinase-Associated Lipocalin as a Predictor of Glomerular Filtration Rate and Amikacin Clearance During Early Rat Endotoxemia: Comparison with Traditional Endogenous and Exogenous Biomarkers"],"prefix":"10.1007","volume":"45","author":[{"given":"\u0160\u00e1rka","family":"Studen\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Dole\u017eelov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolana","family":"Cermanov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alena","family":"Pra\u0161nick\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Drahom\u00edra","family":"Springer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanislav","family":"Mi\u010duda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9052-6318","authenticated-orcid":false,"given":"Jaroslav","family":"Chl\u00e1dek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,11]]},"reference":[{"key":"579_CR1","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1445-5994.2011.02452.x","volume":"41","author":"ML Avent","year":"2011","unstructured":"Avent ML, Rogers BA, Cheng AC, Paterson DL. Current use of aminoglycosides: indications, pharmacokinetics and monitoring for toxicity. Intern Med J. 2011;41:441\u20139.","journal-title":"Intern Med J"},{"key":"579_CR2","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.2165\/11597020-000000000-00000","volume":"71","author":"S Pagkalis","year":"2011","unstructured":"Pagkalis S, Mantadakis E, Mavros MN, Ammari C, Falagas ME. Pharmacological considerations for the proper clinical use of aminoglycosides. Drugs. 2011;71:2277\u201394.","journal-title":"Drugs"},{"key":"579_CR3","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2133\/dmpk.19.159","volume":"19","author":"J Nagai","year":"2004","unstructured":"Nagai J, Takano M. Molecular aspects of renal handling of aminoglycosides and strategies for preventing the nephrotoxicity. Drug Metab Pharmacokinet. 2004;19:159\u201370.","journal-title":"Drug Metab Pharmacokinet"},{"key":"579_CR4","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s40262-016-0428-x","volume":"56","author":"A Marsot","year":"2017","unstructured":"Marsot A, Guilhaumou R, Riff C, Blin O. Amikacin in critically ill patients: a review of population pharmacokinetic studies. Clin Pharmacokinet. 2017;56:127\u201338.","journal-title":"Clin Pharmacokinet"},{"key":"579_CR5","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1053\/j.ackd.2017.10.006","volume":"25","author":"JC Seegmiller","year":"2018","unstructured":"Seegmiller JC, Eckfeldt JH, Lieske JC. Challenges in measuring glomerular filtration rate: a clinical laboratory perspective. Adv Chronic Kidney Dis. 2018;25:84\u201392.","journal-title":"Adv Chronic Kidney Dis"},{"key":"579_CR6","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s10534-005-3251-7","volume":"19","author":"N Borregaard","year":"2006","unstructured":"Borregaard N, Cowland JB. Neutrophil gelatinase-associated lipocalin, a siderophore-binding eukaryotic protein. Biometals. 2006;19:211\u20135.","journal-title":"Biometals"},{"key":"579_CR7","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/sj.ki.5002165","volume":"71","author":"K Mori","year":"2007","unstructured":"Mori K, Nakao K. Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. Kidney Int. 2007;71:967\u201370.","journal-title":"Kidney Int"},{"key":"579_CR8","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/apha.12764","volume":"219","author":"EV Schrezenmeier","year":"2017","unstructured":"Schrezenmeier EV, Barasch J, Budde K, Westhoff T, Schmidt-Ott KM. Biomarkers in acute kidney injury \u2013pathophysiological basis and clinical performance. Acta Physiol. 2017;219:554\u201372.","journal-title":"Acta Physiol"},{"issue":"4","key":"579_CR9","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s11255-017-1781-x","volume":"50","author":"BM Beker","year":"2018","unstructured":"Beker BM, Corleto MG, Fieiras C, Musso CG. Novel acute kidney injury biomarkers: their characteristics, utility and concerns. Int Urol Nephrol. 2018;50(4):705\u201313.","journal-title":"Int Urol Nephrol"},{"key":"579_CR10","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/jac\/dkw351","volume":"72","author":"KJ Downes","year":"2017","unstructured":"Downes KJ, Dong M, Fukuda T, Clancy JP, Haffner C, Bennett MR, et al. Urinary kidney injury biomarkers and tobramycin clearance among children and young adults with cystic fibrosis: a population pharmacokinetic analysis. J Antimicrob Chemother. 2017;72:254\u201360.","journal-title":"J Antimicrob Chemother"},{"key":"579_CR11","doi-asserted-by":"publisher","first-page":"R130","DOI":"10.1186\/cc7990","volume":"13","author":"A Morelli","year":"2009","unstructured":"Morelli A, Ertmer C, Rehberg S, Lange M, Orecchioni A, Cecchini V, et al. Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study. Crit Care. 2009;13:R130.","journal-title":"Crit Care"},{"key":"579_CR12","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.jss.2014.01.053","volume":"188","author":"X Qiu","year":"2014","unstructured":"Qiu X, Huang Y, Xu J, Qiu H, Yang Y. Effects of terlipressin on microcirculation of small bowel mesentery in rats with endotoxic shock. J Surg Res. 2014;188:503\u20139.","journal-title":"J Surg Res"},{"key":"579_CR13","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s00210-006-0067-0","volume":"373","author":"J Pill","year":"2006","unstructured":"Pill J, Issaeva O, Woderer S, Sadick M, Kr\u00e4nzlin B, Fiedler F, et al. Pharmacological profile and toxicity of fluorescein-labelled sinistrin, a novel marker for GFR measurements. Naunyn Schmiedebergs Arch Pharmacol. 2006;373:204\u201311.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"579_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1006\/abio.2000.4893","volume":"289","author":"J Woitzik","year":"2001","unstructured":"Woitzik J, Abromeit N, Schaefer F. Measurement of nitric oxide metabolites in brain microdialysates by a sensitive fluorometric high-performance liquid chromatography assay. Anal Biochem. 2001;289:10\u20137.","journal-title":"Anal Biochem"},{"key":"579_CR15","doi-asserted-by":"publisher","first-page":"F388","DOI":"10.1152\/ajprenal.00266.2014","volume":"308","author":"Z Kadova","year":"2015","unstructured":"Kadova Z, Dolezelova E, Cermanova J, Hroch M, Laho T, Muchova L, et al. IL-1 receptor blockade alleviates endotoxin-mediated impairment of renal drug excretory functions in rats. Am J Physiol Renal Physiol. 2015;308:F388\u201399.","journal-title":"Am J Physiol Renal Physiol"},{"key":"579_CR16","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3343\/alm.2017.37.5.388","volume":"37","author":"H Kim","year":"2017","unstructured":"Kim H, Hur M, Lee S, Marino R, Magrini L, Cardelli P, et al. Proenkephalin, neutrophil gelatinase-associated lipocalin, and estimated glomerular filtration rates in patients with sepsis. Ann Lab Med. 2017;37:388\u201397.","journal-title":"Ann Lab Med"},{"key":"579_CR17","doi-asserted-by":"publisher","first-page":"e0124429","DOI":"10.1371\/journal.pone.0124429","volume":"10","author":"GP Otto","year":"2015","unstructured":"Otto GP, Hurtado-Oliveros J, Chung HY, Knoll K, Neumann T, M\u00fcller HJ, et al. Plasma neutrophil gelatinase-associated lipocalin is primarily related to inflammation during sepsis: a translational approach. PLoS One. 2015;10:e0124429.","journal-title":"PLoS One"},{"key":"579_CR18","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.ijantimicag.2010.07.015","volume":"36","author":"MG Kees","year":"2010","unstructured":"Kees MG, Hilpert JW, Gnewuch C, Kees F, Voegeler S. Clearance of vancomycin during continuous infusion in intensive care unit patients: correlation with measured and estimated creatinine clearance and serum cystatin C. Int J Antimicrob Agents. 2010;36:545\u20138.","journal-title":"Int J Antimicrob Agents"},{"key":"579_CR19","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/jcph.600","volume":"56","author":"MG Kees","year":"2016","unstructured":"Kees MG, Minichmayr IK, Moritz S, Beck S, Wicha SG, Kees F, et al. Population pharmacokinetics of meropenem during continuous infusion in surgical ICU patients. J Clin Pharmacol. 2016;56:307\u201315.","journal-title":"J Clin Pharmacol"},{"key":"579_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2369-13-25","volume":"13","author":"M Han","year":"2012","unstructured":"Han M, Li Y, Liu M, Li Y, Cong B. Renal neutrophil gelatinase associated lipocalin expression in lipopolysaccharide-induced acute kidney injury in the rat. BMC Nephrol. 2012;13:25.","journal-title":"BMC Nephrol"},{"key":"579_CR21","doi-asserted-by":"publisher","first-page":"e821","DOI":"10.1097\/CCM.0000000000002381","volume":"45","author":"N Arulkumaran","year":"2017","unstructured":"Arulkumaran N, Sixma ML, Jentho E, Ceravola E, Bass PS, Kellum JA, et al. Sequential analysis of a panel of biomarkers and pathologic findings in a resuscitated rat model of sepsis and recovery. Crit Care Med. 2017;45:e821\u201330.","journal-title":"Crit Care Med"},{"key":"579_CR22","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1186\/cc12540","volume":"17","author":"GP Otto","year":"2013","unstructured":"Otto GP, Busch M, Sossdorf M, Claus RA. Impact of sepsis-associated cytokine storm on plasma NGAL during acute kidney injury in a model of polymicrobial sepsis. Crit Care. 2013;17:419.","journal-title":"Crit Care"},{"key":"579_CR23","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3109\/00365519509110257","volume":"55","author":"L Axelsson","year":"1995","unstructured":"Axelsson L, Bergenfeldt M, Ohlsson K. Studies of the release and turnover of a human neutrophil lipocalin. Scand J Clin Lab Investig. 1995;55:577\u201388.","journal-title":"Scand J Clin Lab Investig"},{"key":"579_CR24","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1172\/JCI23056","volume":"115","author":"K Mori","year":"2005","unstructured":"Mori K, Lee HT, Rapoport D, Drexler IR, Foster K, Yang J, et al. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Investig. 2005;115:610\u201321.","journal-title":"J Clin Investig"},{"key":"579_CR25","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3109\/1354750X.2013.787460","volume":"18","author":"J M\u00e5rtensson","year":"2013","unstructured":"M\u00e5rtensson J, Bell M, Xu S, Bottai M, Ravn B, Venge P, et al. Association of plasma neutrophil gelatinase-associated lipocalin (NGAL) with sepsis and acute kidney dysfunction. Biomarkers. 2013;18:349\u201356.","journal-title":"Biomarkers"},{"key":"579_CR26","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1128\/AAC.34.4.576","volume":"34","author":"D Tardif","year":"1990","unstructured":"Tardif D, Beauchamp D, Bergeron MG. Influence of endotoxin on the intracortical accumulation kinetics of gentamicin in rats. Antimicrob Agents Chemother. 1990;34:576\u201380.","journal-title":"Antimicrob Agents Chemother"},{"key":"579_CR27","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1097\/CCM.0b013e3181961bff","volume":"37","author":"JA Roberts","year":"2009","unstructured":"Roberts JA. Pharmacokinetic issues for antibiotics in the critically ill patient. Crit Care Med. 2009;37:840\u201351.","journal-title":"Crit Care Med"},{"key":"579_CR28","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1189\/jlb.0806542","volume":"81","author":"D Rittirsch","year":"2007","unstructured":"Rittirsch D, Hoesel LM, Ward PA. The disconnect between animal models of sepsis and human sepsis. J Leukoc Biol. 2007;81:137\u201343.","journal-title":"J Leukoc Biol"}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-019-00579-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13318-019-00579-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-019-00579-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T23:05:15Z","timestamp":1602284715000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13318-019-00579-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,11]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["579"],"URL":"https:\/\/doi.org\/10.1007\/s13318-019-00579-3","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"type":"print","value":"0378-7966"},{"type":"electronic","value":"2107-0180"}],"subject":[],"published":{"date-parts":[[2019,10,11]]},"assertion":[{"value":"11 October 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This study was supported by the grant from the Grant Agency of Charles University Progres Q40.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Animal Welfare Committee at the Charles University in Prague, Faculty of Medicine in Hradec Kralove. The animals received humane care according to the ethical standards of Directive 86\/609\/EEC, \u201cEuropean Convention for the Protection of Vertebrate Animals Used for Experimental and other Scientific Purposes\u201d (1986), and the \u201cGuiding Principles in the Use of Animals in Toxicology\u201d (1989).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}